Cramer, Jakob P <br/><br/>
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIAROŽ in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.  [electronic resource] 

 -  Vaccine  08 2016 
 - 4579-4585 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2016.07.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Viral--blood<br/>Austria<br/>Encephalitis, Japanese--prevention & control<br/>Female<br/>Germany<br/>Humans<br/>Immunization, Secondary<br/>Immunogenicity, Vaccine<br/>Japanese Encephalitis Vaccines--adverse effects<br/>Male<br/>Prospective Studies<br/>Seroconversion